Patients with advanced Hodgkin's or non-Hodgkin's lymphoma who undergo an autologous BMT have a 25 to 50 percent chance of long term survival. Without a BMT, their chances for long term survival are 5 to 10 percent. The prognosis for long-term survival varies according to the disease being treated, the stage of the disease at which an autologous BMT was performed, the patient's age, prior treatment history, and any complications that may have developed during transplant. Nonetheless, the alternative is usually near-certain death. Each added day of life, therefore, is special.
Most patients agree that the potential rewards of an autologous BMT are well worth the effort.
If you or a loved one is seeking more information about transplants, I advise you to order a copy of this book from their website. Their is no cost, but they do ask for donations.